市場調查報告書

藥物安全檢測市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Pharmacovigilance Market, By Type of Clinical Trial Phases, By Type of Method, By Type of Service Providers, By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968705
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
藥物安全檢測市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Pharmacovigilance Market, By Type of Clinical Trial Phases, By Type of Method, By Type of Service Providers, By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月15日內容資訊: 英文 175 Pages
簡介

藥物安全檢測是對藥物安全性和有效性的研究。預計在預測期內,副作用不斷增加以及政府監管機構實施安全法規將推動藥物警戒市場的增長。

本報告提供全球藥物安全檢測市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • M&A

第4章 全球藥物安全檢測市場:各臨床試驗階段

  • 簡介
  • 前臨床
  • 階段I
  • 階段II
  • 階段III
  • 上市後監測 (PMS) 或階段IV

第5章 全球藥物安全檢測市場:各方法類型

  • 簡介
  • 自發報告
  • ADR報告的強化
  • 標的報告
  • 世代心臟事件記錄器
  • EHR監測

第6章 全球藥物安全檢測市場:各服務供應商類型

  • 簡介
  • 公司內部
  • 外部委託

第7章 全球藥物安全檢測市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 企業簡介
    • Accenture Plc
    • Bristol-Myers Squibb
    • Clinquest Group BV
    • Cognizant Technology Solutions
    • Covance, Inc.
    • GlaxoSmithKline, ICON, Plc
    • iGATE Corporation
    • iMEDGlobal Corporation
    • Diamond Pharma Services
    • Infosys
    • Ergomed plc
    • inVentiv Health Inc.
    • APCER Life Sciences
    • ArisGlobal
    • Johnson and Johnson

第9章 章節

目錄

Title:
Pharmacovigilance Market, By Type of Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring), By Type of Service Providers (In-House, Contract Outsourcing), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Pharmacovigilance market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Pharmacovigilance market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation. Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, and Johnson and Johnson
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pharmacovigilance market

Detailed Segmentation:

  • Global Pharmacovigilance Market, By Type of Clinical Trial Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
  • Global Pharmacovigilance Market, By Type of Method:
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
  • Global Pharmacovigilance Market, By Type of Service Providers:
    • In-House
    • Contract Outsourcing
  • Global Pharmacovigilance Market, By Region:
  • North America
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Accenture Plc *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions
  • Covance, Inc.
  • GlaxoSmithKline
  • ICON, Plc
  • iGATE Corporation
  • Arriello
  • iMEDGlobal Corporation
  • Diamond Pharma Services
  • Infosys
  • Ergomed plc
  • inVentiv Health Inc.
  • APCER Life Sciences
  • ArisGlobal
  • Johnson and Johnson
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Clinical Trail Phases
    • Market Snippet, By Type of Method
    • Market Snippet, By Type of Service Providers
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Pharmacovigilance Market, By Clinical Trail Phases, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pre-clinical Studies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Clinical Trial Phase I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Clinical Trial Phase II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Clinical Trial Phase III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Post Marketing Surveillance or Phase IV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Pharmacovigilance Market, By Type of Method, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Spontaneous Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Intensified ADR Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Targeted Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Cohort Event Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • EHR Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Pharmacovigilance Market, By Type of Service Providers, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • In-House
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Contract Outsourcing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Pharmacovigilance Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Clinical Trail Phases, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture Plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Clinquest Group B.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cognizant Technology Solutions
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Covance, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline, ICON, Plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • iGATE Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • iMEDGlobal Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Diamond Pharma Services
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Infosys
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Ergomed plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • inVentiv Health Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • APCER Life Sciences
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ArisGlobal
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact